This blood cancer is on the rise, and its impact on children and adults is different, requiring awareness of how it affects ...

Researchers explore TAF1's role in leukemia, revealing potential targeted therapies that could transform treatment approaches ...

In the past 25 years — from 2000 to 2024 — we have witnessed a revolution in the management, treatment, and outcome of what used to be the most lethal hematologic cancer: Philadelphia ...

Novel therapies and dosing schedules that improve outcomes and toxicities across a range of adult leukemias are among the clinical advances presented at the 2024 American Society of Clinical Oncology ...

Medically reviewed by Archana Sharma, DO Acute myeloid leukemia (AML) is a type of leukemia, a cancer of the blood and bone marrow. AML specifically affects the myeloid cells, which are immature white ...

Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: Analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients. This is an ASCO Meeting Abstract from the ...

Phase 1b–2 trial evaluates the potential of CAR T-cell therapy obe-cel in relapsed or refractory B-cell ALL patients. Chimeric antigen receptor (CAR) T-cell therapy has shown promise in inducing ...

World Leukemia Day's central message is simple: Be Leukemia Aware. Learning about the symptoms and taking notice when ...

NEW YORK (Reuters Health) - Adolescents and young adults with leukemia or lymphoma still fare worse than children with these blood cancers, but new research shows things are getting better. "There's ...

Researchers recently calculated the estimated savings over a 30-year period with regard to CML patients who attempt to get off their TKI therapy. In what they referred to as a 'conservative' estimate, ...